Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$6,044 Mln
P/E Ratio
--
P/B Ratio
2.15
Industry P/E
49.48
Debt to Equity
0.76
ROE
-0.02 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-0.15
CFO
$753.65 Mln
EBITDA
$1,709.55 Mln
Net Profit
$279.00 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
R1 RCM (RCM)
| 35.38 | 0.42 | 1.92 | 34.11 | -17.19 | 2.68 | 6.12 |
|
BSE Sensex*
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|
|
R1 RCM (RCM)
| 297.35 | -3.47 | 6.12 | 85.05 | 63.27 | 79.69 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2.14 | 15.74 | -- | -51.08 |
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the... revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah. As of November 19, 2024, R1 RCM Inc. was taken private. Read more
CEO & Director
Mr. Lee Rivas
CEO & Director
Mr. Lee Rivas
Headquarters
Murray, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of R1 RCM Inc (RCM) stood at $ 6,179 Mln as on 30-Sep-24
The share price of R1 RCM Inc (RCM) is $14.31 (NASDAQ) as of 20-Nov-2024 09:30 EDT. R1 RCM Inc (RCM) has given a return of -17.19% in the last 3 years.
R1 RCM Inc (RCM) has a market capitalisation of $ 6,044 Mln as on 08-Jan-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of R1 RCM Inc (RCM) is 2.15 times as on 08-Jan-2025, a 17% discount to its peers’ median range of 2.59 times.
Since, TTM earnings of R1 RCM Inc (RCM) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the R1 RCM Inc (RCM) and enter the required number of quantities and click on buy to purchase the shares of R1 RCM Inc (RCM).
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. R1 RCM Inc. was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. The company was incorporated in 2003 and is headquartered in Murray, Utah. As of November 19, 2024, R1 RCM Inc. was taken private.
The CEO & director of Mr. Lee Rivas. is R1 RCM Inc (RCM), and CFO & Sr. VP is Mr. Lee Rivas.
There is no promoter pledging in R1 RCM Inc (RCM).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
2
|
| R1 RCM Inc. (RCM) | Ratios |
|---|---|
|
Return on equity(%)
|
-2.17
|
|
Operating margin(%)
|
0.91
|
|
Net Margin(%)
|
-2.48
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of R1 RCM Inc (RCM) was $0 Mln.
